| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | +380.1% | -16.7% |
| R&D Expense | $1.2M | +7.9% | +66.0% |
| SG&A Expense | $4.8M | -65.7% | +124.0% |
| Operating Income | -$5.1M | +65.5% | -178.3% |
| Income Tax | $0 | — | — |
| Net Income | -$4.5M | +66.3% | -173.2% |
| EPS (Basic) | -$0.24 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $939K | -46.8% | +188.8% |
| Accounts Receivable | $1.1M | +217.5% | -33.5% |
| Inventory | $4.3M | -0.3% | -24.8% |
| Current Assets | $9.6M | +8.8% | -8.2% |
| Total Assets | $16.8M | -1.4% | -8.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.3M | — | — |
| Capital Expenditures | $57K | — | — |
| Investing Cash Flow | -$397K | — | — |
| Financing Cash Flow | $13.3M | — | — |
| Free Cash Flow | -$12.4M | — | — |
| +90.3% |
| EPS (Diluted) | -$0.24 | +88.7% | +90.3% |
| $12.9M |
| -2.6% |
| +42.8% |
| Long-term Debt | $3.0M | -41.9% | +25.0% |
| Total Liabilities | $18.7M | -5.8% | +21.8% |
| Stockholders' Equity | -$1.4M | +46.0% | -146.8% |